[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 12, 1922


JAMA. 1922;79(7):560-561. doi:10.1001/jama.1922.02640070048019

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Unless prompt action is taken, the people of the United States may soon be paying exorbitant tribute to Germany once more as the price of recovery from disease and of the maintenance of health. Caught between the opposing forces in the conflict between the importers of German dyes and American dye makers, now being carried on in the Senate in connection with tariff legislation, the synthetic drug industry in the United States, built up as a result of lessons learned during the World War, is threatened with extinction. Again German domination of our drug markets looms up as a not remote possibility.

Those synthetic drugs found to be of service in the relief of suffering are mostly side products in the manufacture of dyes from coal tar, and their production, on a commercial basis, is not possible except when carried on along with the dye industry. With the outbreak of

First Page Preview View Large
First page PDF preview
First page PDF preview